Frédéric Tangy

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli

Darragh Duffy, Vincent Rouilly, Valentina Libri et al. · Immunity · 2014 · 241 citations · Full text

Life Sciences, Biomedical Sciences, Immunology +17

Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges

Barbara Piasecka, Darragh Duffy, Alejandra Urrutia et al. · Proceedings of the National Academy of Sciences · 2017 · 238 citations · Full text

Life Sciences, Genetics, Immunology +17

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas et al. · The Lancet Infectious Diseases · 2015 · 233 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15